Conformation of ligands bound to the muscarinic acetylcholine receptor

Molecular Pharmacology

Volumn 62, Issue 4, 2002, Pages 778-787

  Furukawa, Hiroyasu ^a,d   Hamada, Toshiyuki ^d,f   Hayashi, Mariko K ^a   Haga, Tatsuya ^a,e   Muto, Yutaka ^f   Hirota, Hiroshi ^d,f   Yokoyama, Shigeyuki ^b,f   Nagasawa, Kazuo ^c   Ishiguro, Masaji ^g  

^a University of Tokyo   (Japan)

^b Department of Chemistry   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e GAKUSHUIN UNIVERSITY   (Japan)

^f RIKEN YOKOHAMA INSTITUTE   (Japan)

^g SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE DERIVATIVE; BIOGENIC AMINE; G PROTEIN COUPLED RECEPTOR; METHACHOLINE; MUSCARINE; MUSCARINIC M2 RECEPTOR; RHODOPSIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; INSECT CELL; LIGAND BINDING; MOLECULAR MODEL; MUTANT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY;

ANIMALS; BINDING SITES; CELLS, CULTURED; GTP-BINDING PROTEINS; INSECTS; METHACHOLINE CHLORIDE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUSCARINE; MUSCARINIC AGONISTS; MUTATION; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036783718     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.4.778     Document Type: Article

References (43)

1. Baker RW, Chothia CH, Pauling P, and Petcher TJ (1971) Structure and activity of muscarinic stimulants, Nature (Lond) 230:439-45.
2. Behling RW, Yamane T, Navon G, and Jelinski LW (1988) Conformation of acetylcholine bound to the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 85:6721-6725.
3. Bonner TI, Buckley NJ, Young AC, and Brann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science (Wash DC) 237:527-532.
4. Bonner TI, Young AC, Brann MR, and Buckley NJ (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1:403-410.
5. Borhan B, Souto ML, Imai H, Shichida Y, and Nakanishi K (2000) Movement of retinal along the visual transduction path. Science (Wash DC) 288:2209-2212.
6. Casy AF (1975) Stereochemical aspects of parasympathomimetics and their antagonists: recent developments. Prog Med Chern 11:1-65.
7. Casy AF, Hassan MM, and Wu EC (1971) Conformation of some acetylcholine analogs as solutes in deuterium oxide and other solvents. J Pharm Sci 60:67-73.
8. Chothia C and Pauling P (1970) Absolute configuration of cholinergic molecules; the crystal structure of (plus)-trans-2-aceoxy cyclopropyl trimethylammonium iodide. Nature (Load) 226:541-542.
9. Clore GM and Gronenborn AM (1982) Theory and application of the transferred nuclear Overhauser effect to the study of the conformations of small ligands bound to proteins. J Magn Reson 48:402-417.
10. Farrens DL, Altenbach C, Yang K, Hubbell WL, and Khorana HG (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science (Wash DC) 274:768-70.
11. Flower DR (1999) Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1422:207-234.
12. Furukawa H and Haga T (2000) Expression of functional M2 muscarinic acetylcholine receptor in Escherichia coli. J Biochern 127:151-161.
13. 2 muscarinic acetylcholine receptor Life Sci 68:2621.
14. Gilman AG (1987) G proteins: transducers of receptor-generated signals. Annu Rev Biochern 56:615-649.
15. Grisshammer R and Tate CG (1995) Overexpression of integral membrane proteins for structural studies. Q Rev Biophys 28:315-422.
16. Guo ZD, Suga H, Okamura M, Takeda S, and Haga T (2001) Receptor-Galpha fusion proteins as a tool for ligand screening. Life Sci 68:2319-2312.
17. Haasnoot CAG, de Leeuw FAAM, and Altona C (1980) The relationship between proton-proton NMR coupling constants and substituent electronegativities-I. Tetrahedron 36:2783-2792.
18. Haga K and Haga T (1985) Purification of the muscarinic acetylcholine receptor from porcine brain. J Biol Chern 260:7927-7935.
19. Haga K, Haga T, and Ichiyama A (1986) Reconstitution of the muscarinic acetylcholine receptor. Guanine nucleotide-sensitive high affinity binding of agonists to purified muscarinic receptors reconstituted with GTP-binding proteins (Gi and Go). J Biol Chern 261:10133-10140.
20. Haga T and Haga K (1987) Interaction of the muscarinic acetylcholine receptor and GTP binding proteins. Biomed Res 8:149-156.
21. Hayashi MK and Haga T (1996) Purification and functional reconstitution with GTP-binding regulatory proteins of hexahistidine-tagged muscarinic acetylcholine receptors (m2 subtype). J Biochem 120:1232-1238.
22. Hulme EC, Berrie CP, Birdsall NJ, Jameson M, and Stockton JM (1983) Regulation of muscarinic agonist binding by cations and guanine nucleotides. Eur J Pharmacol 94:59-72.
23. Inooka H, Ohtaki T, Kitahara O, Ikegami T, Endo S, Kitada C, Ogi K, Onda H, Fujino M, and Shirakawa M (2001) Conformation of a peptide ligand bound to its G-protein coupled receptor. Nat Struct Biol 8:161-5.
24. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Haga K, Ichiyama A, Kangawa K, et al. (1986) Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (Lond) 323:411-416.
25. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, and Morikawa K (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (Lond) 407:971-7.
26. Lewis NJ, Barker KK, Fox RM Jr, and Mertes MP (1973) Diacetoxypiperidinium analogs of acetylcholine. J Med Chem 16:156-159.
27. Lu ZL and Hulme EC (1999) The functional topography of transmembrane domain 3 of the M1 muscarinic acetylcholine receptor, revealed by scanning mutagenesis. J Biol Chem 274:7309-7315.
28. Lu ZL, Saldanha JW, and Hulme EC (2001) Transmembrane domains 4 and 7 of the M1 muscarinic acetylcholine receptor are critical for ligand binding and the receptor activation switch. J Biol Chem 276:34098-34104.
29. Nelson WL and Wilson RS (1971) Conformationally rigid neurotransmitters. Acetylcholine analogs in the bicyclo(2.2.2)octane system. J Med Chem 14:169-171.
30. Page KM, Curtis CA, Jones PG, and Hulme EC (1995) The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by sitedirected mutagenesis. Eur J Pharmacol 289:429-437.
31. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science (Wash DC) 289:739-745.
32. Partington P, Feeney J, and Burgen AS (1972) The conformation of acetylcholine and related compounds in aqueous solution as studied by nuclear magnetic resonance spectroscopy. Mol Pharmacol 8:269-277.
33. Peralta EG, Winslow JW, Peterson GL, Smith DH, Ashkenazi A, Ramachandran J, Schimerlik MI, and Capon DJ (1987) Primary structure and biochemical properties of an M2 muscarinic receptor. Science (Wash DC) 236:600-605.
34. Portoghese PS (1970) Relationships between stereostructure and pharmacological activities. Annu Rev Pharmacol 10:51-76.
35. Schulman JM, Sabio ML, and Disch RL (1983) Recognition of cholinergic agonists by the muscarinic receptor. 1. Acetylcholine and other agonists with the NCCOCC backbone. J Med Chem 26:817-823.
36. sα fusion protein. Eur J Biochem 255:369-82.
37. Shiozaki K and Haga T (1992) Effects of magnesium ion on the interaction of atrial muscarinic acetylcholine receptors and GTP-binding regulatory proteins. Biochemistry. 31:10634-10642.
38. Smissman EE and Chappell GS (1969) A conformational study of beta-phenethanolamine receptor sites. II. The synthesis of the dl-3-phenyl-3-hydroxy-transdecahydroquinolines. J Med Chem 12:429-432.
39. Stephen WF Jr, Smissman EE, Schowen KB, and Self GW (1972) Conformational aspects of systems related to acetylcholine. 3. Base-catalyzed and acetylcholinesterase-catalyzed hydrolysis of the isomeric dl-3-trimethylammonium-2-acetoxytrans-decalin halides and the isomeric dl-1-methyl-3-acetoxy-trans-decahydroquinoline methiodides. J Med Chem 15:241-243.
40. Taylor P and Insel PA (1990) Molecular basis of pharmacologic selectivity, in Principles of Drug Action (Pratt WB, Palmer T eds), 3rd ed, pp 1-74, Churchill Livingstone Inc., New York.
41. Vogel WK, Sheehan DM, and Schimerlik MI (1997) Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling. Mol Pharmacol 52:1087-1094.
42. Ward SD, Curtis CA, and Hulme EC (1999) Alanine-scanning mutagenesis of transmembrane domain 6 of the M1 muscarinic acetylcholine receptor suggests that Tyr381 plays key roles in receptor function. Mol Pharmacol 56:1031-1041.
43. Wess J, Gdula D, and Brann MR (1991) Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. EMBO (Eur Mol Biol Organ) J 10:3729-3734.